国际肿瘤学杂志 ›› 2026, Vol. 53 ›› Issue (11): 655-663.doi: 10.3760/cma.j.cn371439-20260119-00103

• 论著 • 上一篇    下一篇

miR-331-3p调控BCL6/ITGA9轴对腺样囊性癌发生发展的影响

宿江, 周伟, 张华()   

  1. 新疆医科大学第一附属医院耳鼻咽喉科, 乌鲁木齐 830054
  • 收稿日期:2026-01-19 出版日期:2026-11-08 发布日期:2026-11-05
  • 通讯作者: 张华,Email: hzhang1106@163.com
  • 作者简介:

    宿江:实验操作、论文撰写;周伟:数据整理、论文撰写;张华:论文修改、研究指导、经费支持

Regulation of the BCL6/ITGA9 axis by miR-331-3p on the occurrence and development of adenoid cystic carcinoma

Su Jiang, Zhou Wei, Zhang Hua()   

  1. Department of Otolaryngology, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
  • Received:2026-01-19 Online:2026-11-08 Published:2026-11-05

摘要:

目的 探讨miR-331-3p、BCL6和ITGA9的靶向关系,观察其对腺样囊性癌(ACC)细胞增殖、迁移、侵袭和免疫细胞浸润水平的影响。 方法 采用双荧光素酶报告基因实验验证miR-331-3p与BCL6、ITGA9的靶向关系。建立人唾液腺样囊性癌-83(SACC-83)细胞株的miR-331-3p mimic和pcDNA3.1 BCL6转染模型,采用实时荧光定量PCR检测细胞miR-331-3p、BCL6和ITGA9的mRNA表达;蛋白质印迹法检测细胞BCL6和ITGA9蛋白的相对表达量;CCK-8法检测细胞增殖;细胞划痕实验和Transwell实验分别检测细胞的迁移和侵袭。建立ACC转移灶(ACC-M)细胞株的空质粒、过表达ITGA9质粒、过表达BCL6质粒、miRNA NC mimic和miR-331-3p mimic的转染模型,采用蛋白质印迹法检测细胞BCL6和ITGA9的蛋白相对表达量,实时荧光定量PCR检测细胞肿瘤分泌趋化因子CXCL9、CXCL10和CXCL11基因的相对表达量。 结果 双荧光素酶试验结果显示,miR-331-3p可特异性结合BCL6,BCL6可靶向结合ITGA9。mimic+NC组、mimic+BCL6组、mimic NC+BCL6组SACC-83细胞miR-331-3p相对表达量分别为1.01±0.16、0.67±0.05、0.35±0.12;BCL6 mRNA相对表达量分别为1.01±0.21、2.06±0.27、4.48±0.36;ITGA9 mRNA相对表达量分别为1.00±0.04、0.55±0.07、0.35±0.17,差异均有统计学意义(F=22.28,P=0.002;F=116.65,P<0.001;F=26.72,P=0.001);上述3组SACC-83细胞miR-331-3p、ITGA9表达均依次降低,BCL6表达依次升高(均P<0.05)。mimic+NC组、mimic+BCL6组、mimic NC+BCL6组SACC-83细胞ITGA9蛋白相对表达量分别为0.96±0.03、0.87±0.02、0.67±0.05,BCL6蛋白相对表达量分别为0.92±0.01、1.13±0.02、1.72±0.02,差异均有统计学意义(F=61.87,P<0.001;F=7.18,P=0.026);上述3组SACC-83细胞ITGA9蛋白相对表达量依次降低,BCL6蛋白相对表达量依次升高(均P<0.05)。mimic+NC组、mimic+BCL6组和mimic NC+BCL6组SACC-83细胞增殖活性分别为100.00%±6.05%、82.03%±2.47%、53.18%± 5.47%;上述3组细胞凋亡率分别为6.21%±0.23%、15.31%±0.74%、27.47%±1.09%;细胞迁移率分别为54.17%±9.15%、34.37%±5.84%、11.17%±5.25%;细胞侵袭率分别为52.33%±8.74%、36.67%±4.73%、14.00%±2.00%,差异均有统计学意义(F=69.15,P<0.001;F=572.93,P<0.001;F=28.66,P=0.001;F=32.56,P=0.001)。上述3组SACC-83细胞增殖活性、迁移率、侵袭率均依次降低,凋亡率依次升高(均P<0.05)。ACC-M细胞转染ITGA9、miR-331-3p mimic过表达载体后,CXCL9、CXCL10和CXCL11 mRNA相对表达量均降低(均P<0.05);转染BCL6过表达载体后,CXCL9、CXCL10和CXCL11 mRNA相对表达量均升高(均P<0.05)。 结论 miR-331-3p通过抑制BCL6促进ITGA9的表达从而促进ACC细胞的增殖、迁移和侵袭能力,减少肿瘤内杀伤性淋巴细胞的浸润,促进肿瘤进展。

关键词: 癌, 腺样囊性, 微RNAs, 免疫浸润, 信号轴

Abstract:

Objective To investigate the targeting relationships involving miR-331-3p,BCL6 and ITGA9, and to examine their effects on the proliferation, migration, invasion, and immune cell infiltration levels of adenoid cystic carcinoma (ACC) cells. Methods A dual-luciferase reporter assay was employed to verify the targeting relationships among miR-331-3p, BCL6, and ITGA9. The miR-331-3p mimic and cells transfected with pcDNA3.1-BCL6 plasmid were established using salivary adenoid cystic carcinoma-83 (SACC-83) tumor cells. Real-time quantitative PCR was used to detect the mRNA expression levels of miR-331-3p, BCL6, and ITGA9. Western blotting was performed to detect the protein relative expression levels of BCL6 and ITGA9. Cell proliferation was assessed using the CCK-8 assay. Cell migration and invasion were evaluated using scratch wound healing and Transwell assays, respectively. Furthermore, transfection models were established in ACC metastasis (ACC-M) cells using empty vector plasmids, ITGA9 and BCL6 overexpression plasmids, miRNA NC mimic, and miR-331-3p mimic. Western blotting was performed to detect the protein relative expression levels of BCL6 and ITGA9. Real-time quantitative PCR was used to detect the relative expression levels of chemokine genes secreted by tumor cells (CXCL9, CXCL10, and CXCL11). Results The dual luciferase assay results indicated that miR-331-3p could specifically bind to BCL6. BCL6 could specifically bind to ITGA9. In SACC-83 cells, the relative expression levels of miR-331-3p were 1.01±0.16, 0.67±0.05, and 0.35±0.12 in the mimic+NC group, mimic+BCL6 group, and mimic NC+BCL6 group, respectively. The BCL6 mRNA relative expression levels were 1.01±0.21, 2.06±0.27, and 4.48±0.36, respectively, while the ITGA9 mRNA relative expression levels were 1.00±0.04, 0.55±0.07, and 0.35±0.17, respectively, with statistically significant differences (F=22.28, P=0.002; F=116.65, P<0.001; F=26.72, P=0.001). The expression levels of miR-331-3p and ITGA9 decreased progressively, whereas BCL6 expression increased progressively in the above three groups (all P<0.05). The ITGA9 protein relative expression levels in SACC-83 cells were 0.96±0.03, 0.87±0.02, and 0.67±0.05 in the mimic+NC group, mimic+BCL6 group, and mimic NC+BCL6 group, respectively. The BCL6 protein relative expression levels were 0.92±0.01, 1.13±0.02, and 1.72±0.02, respectively, with statistically significant differences (F=61.87, P<0.001; F=7.18, P=0.026). The ITGA9 protein relative expression decreased progressively, while BCL6 protein relative expression increased progressively in the above three groups (all P<0.05). The proliferation activities of SACC-83 cells were 100.00%±6.05%, 82.03%±2.47%, and 53.18%±5.47% in the mimic+NC group, mimic+BCL6 group, and mimic NC+BCL6 group, respectively. The apoptosis rates in these groups were 6.21%±0.23%, 15.31%±0.74%, and 27.47%±1.09%, respectively; migration rates were 54.17%±9.15%, 34.37%±5.84%, and 11.17%±5.25%, respectively; invasion rates were 52.33%±8.74%, 36.67%±4.73%, and 14.00%±2.00%, respectively, with statistically significant differences (F=69.15, P<0.001; F=572.93, P<0.001; F=28.66, P=0.001; F=32.56, P=0.001). The proliferation activity, migration rate, and invasion rate of SACC-83 cells decreased progressively, while the apoptosis rate increased progressively in the above three groups (all P<0.05). After ACC-M cells were transfected with the overexpression vectors of ITGA9 and miR-331-3p mimic, the mRNA relative expression levels of CXCL9, CXCL10, and CXCL11 all decreased (all P<0.05); after transfection with BCL6 vectors respectively, the mRNA relative expression levels of CXCL9, CXCL10, and CXCL11 all increased (all P<0.05). Conclusions miR-331-3p promotes ITGA9 expression by inhibiting BCL6. This regulation enhances the proliferation, migration, and invasion capabilities of ACC cells; reduces the infiltration of cytotoxic lymphocytes within the tumor; and thereby promotes tumor progression.

Key words: Carcinoma, adenoid cystic, MicroRNAs, Immune infiltration, Signaling axis